Skip to main content

Harpoon Therapeutics, Inc.

HARPDelisted Mar 11, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708493

Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Harpoon Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of HARP: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders5249−3
Shares21.7M18.9M−2.81M (−13.0%)
Value$21.0M$13.7M−$7.34M (−34.9%)

New holders (13)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to HARP in Q4 2022
InstitutionSharesValue% of portfolio
Levin Capital Strategies, L.P.330,000$239.5K0.03%
Telemetry Investments, L.L.C.93,000$67.0K0.16%
Sequoia Financial Advisors, LLC60,000$43.5K0.00%
Two Sigma Securities, LLC30,702$22.3K0.00%
Synovus Financial Corp23,000$16.7K0.00%
Susquehanna International Group, LLP20,119$14.6K0.00%
Citadel Advisors LLC14,457$10.5K0.00%
Virtu Financial LLC11,841$9.00K0.00%
Commonwealth Equity Services, LLC10,000$7.00K0.00%
Belpointe Asset Management LLC1,900$1.38K0.00%
FNY Investment Advisers, LLC2,000$1.00K0.00%
GWM Advisors LLC115$830.00%
Cutler Group LP600$00.00%

Sold out (16)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.